Expression of a Truncated Form of the c-Kit Tyrosine Kinase Receptor and Activation of Src Kinase in Human Prostatic Cancer

American Journal of Pathology

Volumn 164, Issue 4, 2004, Pages 1243-1251

  Paronetto, Maria Paola ^a   Farini, Donatella ^a   Sammarco, Innocenzo ^a   Maturo, Giovanni ^a   Vespasiani, Giuseppe ^a   Geremia, Raffaele ^a   Rossi, Pellegrino ^a   Sette, Claudio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE ACTIVATION; GENE ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC TRANSFECTION; GERM CELL; HAPLOIDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; MALE; MALIGNANT TRANSFORMATION; ONCOGENE C KIT; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

EID: 1642292426     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63212-9     Document Type: Article

References (30)

1. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, Bachvarova RF: The kit-ligand (steel factor) and its receptor c-kit/W: Pleiotropic roles in gametogenesis and melanogenesis. Dev Suppl 1993, 125-137
2. Heinrich MC, Blanke CD, Druker BJ, Corless CL: Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002, 20:1692-1703
3. Blume-Jensen P, Hunter T: Oncogenic kinase signalling. Nature 2001, 411:355-365
4. Capdeville R, Buchdunger E, Zimmermann J, Matter A: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 2002, 1:493-502
5. Toyota M, Hinoda Y, Itoh F, Takaoka A, Imai K, Yachi A: Complementary DNA cloning of truncated form of c-kit in human colon carcinoma cells. Cancer Res 1994, 54:272-275
6. Takaoka A, Toyota M, Hinoda Y, Itoh F, Mita H, Kakiuchi H, Adachi M, Imai K: Expression and identification of aberrant c-kit transcripts in human cancer cells. Cancer Lett 1997, 115:257-261
7. Christianson TA, Doherty JK, Lin YJ, Ramsey EE, Holmes R, Keenan EJ, Clinton GM: NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res 1998, 58:5123-5129
8. Wallenius V, Hisaoka M, Helou K, Levan G, Mandahl N, Meis-Kindblom JM, Kindblom LG, Jansson JO: Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol 2000, 156:821-829
9. Egeblad M, Mortensen OH, Jaattela M: Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology. Int J Cancer 2001, 94:185-191
10. Rossi P, Marziali G, Albanesi C, Charlesworth A, Geremia R, Sorrentino V: A novel c-kit transcript, potentially encoding a truncated receptor, originates within a kit gene intron in mouse spermatids. Dev Biol 1992, 152:203-207
11. Albanesi C, Geremia R, Giorgio M, Dolci S, Sette C, Rossi P: A cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongation. Development 1996, 122:1291-1302
12. Sette C, Bevilacqua A, Bianchini A, Mangia F, Geremia R, Rossi P: Parthenogenetic activation of mouse eggs by microinjection of a truncated c-kit tyrosine kinase present in spermatozoa. Development 1997, 124:2267-2274
13. Sette C, Paronetto MP, Barchi M, Bevilacqua A, Geremia R, Rossi P: Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase. EMBO J 2002, 21:5386-5395
14. Sette C, Bevilacqua A, Geremia R, Rossi P: Involvement of phospholipase Cgammal in mouse egg activation induced by a truncated form of the C-kit tyrosine kinase present in spermatozoa. J Cell Biol 1998, 142:1063-1074
15. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R, Yeatman TJ: Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 1999, 21:187-190
16. Paronetto MP, Venables J, Elliot DJ, Geremia R, Rossi P, Sette C: Tr-kit promotes the formation of a multimolecular complex composed of Fyn, PLCγ1 and Sam68. Oncogene 2003, 22:8707-8715
17. Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F: Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 2000, 19:5406-5417
18. Slack JK, Adams RB, Rovin JD, Bissonette EA, Stoker CE, Parsons JT: Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cells. Oncogene 2001, 20:1152-1163
19. Derry JJ, Prins GS, Ray V, Tyner AL: Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 2003, 22:4212-4220
20. Grossmann ME, Huang H, Tindall DJ: Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 2001, 93: 1687-1697
21. Lee LF, Guan J, Qiu Y, Kung HJ: Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase. Mol Cell Biol 2001, 21:8385-8397
22. Zhou J, Scholes J, Hsieh JT: Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer. J Biol Chem 2003, 278:6936-6941
23. Thomas SM, Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997, 13:513-609
24. Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manolagas SC: Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001, 104: 719-730
25. Taylor SJ, Shalloway D: An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 1994, 368:867-871
26. Vernet C, Artzt K: STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 1997, 13:479-484
27. Fusaki N, Iwamatsu A, Iwashima M, Fujisawa J: Interaction between Sam68 and Src family tyrosine kinases, Fyn and Lck, in T cell receptor signaling. J Biol Chem 1997, 272:6214-6219
28. Wang LL, Richard S, Shaw AS: P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem 1995, 270:2010-2013
29. Liu K, Li L, Nisson PE, Gruber C, Jessee J, Cohen SN: Neoplastic transformation and tumorigenesis associated with sam68 protein deficiency in cultured murine fibroblasts. J Biol Chem 2000, 275:40195-40201
30. Webber MM, Bello D, Quader S: Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications, part 2. Tumorigenic cell lines, Prostate 1997, 30:58-64